Understanding the Psychological Benefits and Neurophysiological Mechanisms of Qigong in Older Adults

April 23, 2025 updated by: TSANG Hector Wing-Hong, The Hong Kong Polytechnic University

One goal of the study is to evaluate the efficacy of qigong to alleviate depressive symptoms and enhance cognitive function in comparison to mindfulness-based intervention, physical exercise, and waitlist control. The other goal is to explore the changes in neurobiological markers that may explain the qigong-related effects on depressive symptoms and cognitive function. The main research questions are:

  • Is the 12-week qigong training more effective than mindfulness-based intervention, physical exercise, and waitlist control to alleviate depressive symptoms?
  • Is the 12-week qigong training more effective than mindfulness-based intervention, physical exercise, and waitlist control to enhance cognitive function?

Participants are older adults aged 60 or above. They were randomly assigned to qigong training, mindfulness training, physical exercise training, or wait-list which all last for 12 weeks. Their changes before and after the 12-week period in depressive symptoms, neurobiological markers, and cognitive functions are assessed.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Kowloon, Hong Kong
        • Hong Kong Polytechnic University, Department of Rehabilitation Sciences
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 60 years or older;
  • With mild or severer levels of depressive symptoms as indicated by the Geriatric Depression Scale (GDS-8) scores of 5 or above, or Depression Anxiety and Stress Scale-21 (DASS-21) depression subscale scores of 4 or above
  • Self-identified as physically stable and without life-threatening diseases.
  • Be able to communicate in Cantonese or Mandarin.

Exclusion Criteria:

  • Have a history of practicing or receiving training of any form of mind-body or regular exercises (including tai chi, yoga, and qigong, or regular physical activity > 3 times/week) during the month prior to intervention
  • Have changed medications or the dose of medications prescribed for their health condition in the one month prior to study enrollment
  • Have severe cognitive or language impairment based on the assessment with Montreal Cognitive Assessment (MoCA)
  • Taking medication or undergoing electroconvulsive therapy, psychotherapy, or psychoeducation for a psychological or psychiatric condition
  • Unable to demonstrate satisfactory standing balance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Qigong (Baduanjin)
12-week training of Baduanjin, with two sessions per week. Each session lasts for 60 min.
Participants will receive 24 sessions of Baduanjin training over 12 weeks (2 sessions per week). Each session will last for 60 minutes. Baduanjin consists of eight forms of gentle movements, and it takes about 10 to 15 minutes to complete a full cycle. Participants will learn to practice each form gradually over the first 12 sessions. In the remaining 12 sessions, the participants will go through all the movements 2-3 times, with guided practice on rhythmic breathing and mind regulation (attention to body and breathing) to be performed in coordination with the movements. The training will be delivered by an instructor after training by the project team.
Active Comparator: Mindfulness-based intervention
12-week training of mindfulness-based breathing, walking, and stretching practices, with two sessions per week. Each session lasts for 60 min.
Participants will receive mindfulness-based intervention with the same duration and frequency as qigong group. The intervention incorporates psychoeducation on mindfulness and stress management and group-based mindfulness practice about breathing, awareness of body sensations, thoughts, stretching, and walking. All the mindfulness practices are based on publicly accessible audio recordings. The training will be delivered by an instructor after training by the project team.
Active Comparator: Physical exercise
12-week training of stretching, flexibility exercise, and balance exercise, with two sessions per week. Each session lasts for 60 min.
Participants of the physical exercise group will receive training of a series of low-to-moderate intensity physical activities for the same duration and frequency as qigong group. The physical activities include stretching, flexibility exercise, balance exercise, and aerobic exercise. The training will be delivered by an instructor after training by the project team.
No Intervention: Waitlist control
Participants of the waitlist control group will not receive any training while the other three group are having their interventions. After the completion of the all assessments, the participants will receive the 12-week qigong training, same as the qigong group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive symptoms
Time Frame: Baseline and post-intervention (12 weeks after baseline)
The eight-item Patient Health Questionnaire
Baseline and post-intervention (12 weeks after baseline)
Global cognitive function
Time Frame: Baseline and post-intervention (12 weeks after baseline)
Montreal Cognitive Assessment
Baseline and post-intervention (12 weeks after baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum adiponectin
Time Frame: Baseline and post-intervention (12 weeks after baseline)
Collected and assayed through peripheral blood sample
Baseline and post-intervention (12 weeks after baseline)
Serum BDNF
Time Frame: Baseline and post-intervention (12 weeks after baseline)
Collected and assayed through peripheral blood sample
Baseline and post-intervention (12 weeks after baseline)
Salivary cortisol
Time Frame: Baseline and post-intervention (12 weeks after baseline)
Collected and assayed through saliva sample
Baseline and post-intervention (12 weeks after baseline)
Attention
Time Frame: Baseline and post-intervention (12 weeks after baseline)
Attention Network Task
Baseline and post-intervention (12 weeks after baseline)
Inhibitory control
Time Frame: Baseline and post-intervention (12 weeks after baseline)
Attention Network Task
Baseline and post-intervention (12 weeks after baseline)
Working memory
Time Frame: Baseline and post-intervention (12 weeks after baseline)
N-back Task
Baseline and post-intervention (12 weeks after baseline)
ERP N2 amplitude
Time Frame: Baseline and post-intervention (12 weeks after baseline)
ERP data recorded during Attention Network Task and N-back Task
Baseline and post-intervention (12 weeks after baseline)
ERP P3 amplitude
Time Frame: Baseline and post-intervention (12 weeks after baseline)
ERP data recorded during Attention Network Task and N-back Task
Baseline and post-intervention (12 weeks after baseline)
Hand grip strength
Time Frame: Baseline and post-intervention (12 weeks after baseline)
To be assessed with a Jamar handheld dynamometer
Baseline and post-intervention (12 weeks after baseline)
Affect
Time Frame: Baseline and post-intervention (12 weeks after baseline)
Positive and Negative Affect Schedule
Baseline and post-intervention (12 weeks after baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 12, 2025

Primary Completion (Estimated)

March 15, 2026

Study Completion (Estimated)

May 31, 2026

Study Registration Dates

First Submitted

April 23, 2025

First Submitted That Met QC Criteria

April 23, 2025

First Posted (Actual)

April 30, 2025

Study Record Updates

Last Update Posted (Actual)

April 30, 2025

Last Update Submitted That Met QC Criteria

April 23, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 15104721-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Qigong

Clinical Trials on Qigong (Baduanjin)

Subscribe